KYTX
Kyverna Therapeutics, Inc.
6.20$
+0.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 85.9% | 80.7% | 96.3% | 96.1% | 95.9% | 95.4% | 95.0% | 94.6% | 93.5% | 96.3% | 94.0% | 94.0% | |
| 24.8% | 46.1% | 57.5% | 36.2% | 30.9% | 31.7% | 21.8% | 23.6% | 18.3% | 42.2% | 12.5% | 14.5% | |
| 83.6% | 76.5% | 94.8% | 95.4% | 94.8% | 93.9% | 93.1% | 93.5% | 91.4% | 95.0% | 92.0% | 90.7% | |
| 220.9% | 34.6% | 7.4% | 8.2% | 10.8% | 12.5% | 14.1% | 18.6% | 18.8% | 20.9% | 23.9% | 24.7% | |
| 18.2% | 26.4% | 5.6% | 6.5% | 9.1% | 11.1% | 12.8% | 17.6% | 18.1% | 12.4% | 11.5% | 10.4% | |
| 3.0% | 3.9% | 1.0% | 1.1% | 1.2% | 1.3% | 1.4% | 1.6% | 2.0% | 1.4% | 0.8% | 0.7% | |
| 3.3% | 5.8% | 1.9% | 1.3% | 2.9% | 1.5% | 3.3% | 4.4% | 1.6% | 1.8% | 4.5% | 1.3% | |
| – | – | – | – | – | – | – | – | – | 8.4% | 9.7% | 11.3% | |
| -120.9% | 65.4% | 92.6% | 91.8% | 89.2% | 87.5% | 85.9% | 81.4% | 81.2% | 79.1% | 76.1% | 75.3% | |
| -124.7% | -180.9% | -41.7% | -52.7% | -66.6% | -86.5% | -118.2% | -154.6% | -206.8% | -144.6% | -180.7% | -228.8% | |
| 46.6% | 57.3% | 6.1% | 11.9% | 12.7% | 14.2% | 16.6% | 19.1% | 23.2% | 16.0% | 23.5% | 27.7% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.